Search Results 121-130 of 15545 for Humira

  1. Cemiplimab-rwlc (intravenous route) - Mayo Clinic

    Cemiplimab-rwlc injection is used to treat a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread (metastatic) or cannot be cured ...

  2. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to assess the integrated effect of normalization of intestinal dysbiosis through a structured semi-vegetarian dietary intervention ...

  3. Typhoid vaccine, live (oral route) - Mayo Clinic

    Typhoid fever is a serious disease that can cause death. It is caused by a germ called Salmonella typhi, and is spread most often through infected food or water ...

  4. A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor - Mayo Clinic

    Study is a double-blind, randomized, placebo controlled, dose escalating study. The primary objective of this study is to evaluate the safety, tolerability and ...

  5. Pramlintide (subcutaneous route) - Mayo Clinic

    Pramlintide injection is used to treat high blood sugar in patients with type 1 and type 2 diabetes who are also using mealtime insulin and have failed to ...

  6. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...

  7. Prescription weight-loss drugs: Can they help you? - Mayo Clinic

    Bupropion-naltrexone (Contrave); Liraglutide (Saxenda); Orlistat (Xenical, Alli); Phentermine-topiramate (Qsymia); Semaglutide (Wegovy); Setmelanotide (Imcivree).

  8. Olaratumab (intravenous route) - Mayo Clinic

    Olaratumab injection is used in combination with doxorubicin to treat soft tissue sarcoma (STS) in patients who cannot be cured with radiation therapy or ...

  9. SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients - Mayo Clinic

    - To assess the relationship between clinical effects (adverse event [AE] and/or tumor response) and CD38 receptor density at baseline (Part A). Participation ...

  10. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...